R1	Has_value Arg1:T3 Arg2:T4	
R2	Has_value Arg1:T5 Arg2:T6	
R3	AND Arg1:T7 Arg2:T5	
*	OR T8 T9
R4	Has_temporal Arg1:T8 Arg2:T10	
*	OR T14 T13
R5	Has_value Arg1:T19 Arg2:T20	
R6	Has_value Arg1:T21 Arg2:T22	
R7	Has_value Arg1:T23 Arg2:T24	
R8	Has_value Arg1:T25 Arg2:T26	
R9	Has_temporal Arg1:T28 Arg2:T27	
*	OR T16 T23 T28 T21 T19 T18 T17 T25
R10	Has_temporal Arg1:T16 Arg2:T15	
R11	Subsumes Arg1:T12 Arg2:T14	
*	OR T32 T33
*	OR T36 T35
R12	Has_mood Arg1:T31 Arg2:T36	
R13	AND Arg1:T31 Arg2:T32	
R14	Subsumes Arg1:T43 Arg2:T44	
*	OR T42 T43
R15	Has_temporal Arg1:T41 Arg2:T42	
*	OR T46 T47
R16	Has_negation Arg1:T46 Arg2:T48	
R17	AND Arg1:T41 Arg2:T46	
T1	Condition 0 15	Type 1 diabetes
T2	Condition 23 48	peripheral artery disease
T3	Measurement 50 63	Liver enzymes
T4	Value 64 118	equal or more than 1.5 times the upper limit of normal
T5	Measurement 142 146	NYHA
T6	Value 147 162	class III or IV
T7	Condition 120 141	Chronic heart failure
T8	Procedure 172 185	haemodialysis
T9	Procedure 189 208	peritoneal dialysis
T10	Temporal 164 171	Current
T12	Condition 210 233	End stage liver disease
T13	Condition 255 276	chronic liver disease
T14	Condition 246 251;263 276	acute liver disease
T15	Temporal 281 287	recent
T16	Condition 321 328	ascites
T17	Condition 330 344	encephalopathy
T18	Condition 346 363	variceal bleeding
T19	Measurement 365 374	bilirubin
T20	Value 375 406	equal or greater than 2.0 mg/dL
T21	Measurement 408 415	albumin
T22	Value 416 444	equal or less than 3.5 g/ dL
T23	Measurement 446 462	prothrombin time
T24	Value 463 492	greater or equal to 4 seconds
T25	Measurement 494 497	INR
T26	Value 498 526	greater than or equal to 1.7
T27	Temporal 530 535	prior
T28	Procedure 536 552	liver transplant
T31	Condition 573 589	hypersensitivity
T32	Drug 593 607	trial products
T33	Drug 611 627	related products
T35	Mood 563 572	suspected
T36	Mood 554 559	Known
T38	Pregnancy_considerations 629 809	Female of child-bearing potential who is pregnant, breast-feeding or intends to become pregnant or is not using adequate contraceptive methods as required by law or local practice.
T39	Non-query-able 811 915	Expected simultaneous participation in any other clinical trial of an investigational medicinal product.
T40	Non-query-able 917 1001	Receipt of any investigational medicinal product within 30 days before randomization
T41	Condition 1045 1064	malignant neoplasms
T42	Temporal 1003 1010	Current
T43	Temporal 1014 1018	past
T44	Temporal 1020 1043	within the last 5 years
T46	Condition 1073 1083;1107 1116	basal cell carcinoma
T47	Condition 1088 1116	squamous cell skin carcinoma
T48	Negation 1066 1072	except
T50	Post-eligibility 1119 1250	Any condition that in the investigator's opinion would make the subject unable to adhere to the trial visit schedule and procedures
T51	Non-query-able 1252 1296	Known history of non-compliance to treatment
